Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily used for managing type 2 diabetes, whereas Wegovy is specifically approved for weight loss.

Nick Kaye, chairman of the NPA, told the PA news agency: “It is important that consultations with patients are thorough, allowing a clinician to gain a full picture of someone’s suitability for weight loss injections as well as ensuring the patient fully understands the nature of the treatment and any potential side-effects it may cause.

Weight-loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. The NPA has previously urged patients to avoid buying weight loss injections from unregulated online sellers, who may be selling fake drugs.

The National Pharmacy Association is calling for tougher rules in the market, saying people with a history of eating disorders have been wrongly prescribed drugs

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are "concerned that the current regulations allow some patients to inappropriately access weight loss injections without proper consultation or examination of historical medical records".

The National Pharmacy Association (NPA) has written to regulators calling for tougher rules over access to medications like Wegovy and Mounjaro following worrying reports

Pharmacy leaders have issued a warning over the online sale of weight-loss jabs insisting there is still a risk to patient safety.

The pharmacy association said it was worried some patients were accessing the drugs inappropriately amid a surge in demand. View on euronews

It's calling for tougher rules around online sales of the drugs, urging regulator the General Pharmaceutical Council to introduce a required two-way consultation lasting at least 20 minutes before dispensing 'higher-risk' medication.

For many struggling with weight management, new medications like Wegovy, Mounjaro, and Saxenda have been seen as groundbreaking solutions. These drugs, designed to regulate appetite and support weight loss,